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Abstract 
The Notch signaling pathway is a crucial means by which organisms differentiate 
cells during development. Notch is regulated primarily through the interaction of a Notch 
receptor protein and a ligand protein, in two specific ways. Cis-inhibition occurs when both a 
ligand and receptor are present on the same cellular membrane. This results in the cis-ligand 
binding to the receptor and preventing the ligand on an adjacent cell from binding and 
activating the receptor. Alternatively, trans-activation occurs when the ligand and receptor 
are on adjacent cells, and results in the activation of the Notch pathway. Both the receptor 
and ligand proteins are transmembrane proteins that are cleaved first extracellularly by a 
metalloprotease, and then intracellularly by a γ-secretase. While the cleavages in the receptor 
protein have been found to be crucial for proper Notch activation, the role of the ligand 
cleavages is much less well defined. Previous studies have found that the cleavage rate of the 
ligand may be inversely correlated to Notch activation. We postulated that the extracellular 
cleavage of Serrate, a ligand for Notch, by a metalloprotease serves as a means of inhibiting 
Notch activation, possibly by affecting the endocytosis of the ligand molecule. To test this 
hypothesis, we replaced the transmembrane domain of a truncated form of Serrate with that 
region from non-cleavable human tyrosine kinase receptor DDR2 (discoidin domain-receptor 
2),  and show that preventing this cleavage is insufficient to restore Notch activation.  These 
findings suggest that an additional extracellular 65 amino acid segment near the 
transmembrane domain may be necessary to restore wild-type levels of Notch activation.  
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Introduction 
Intercellular communication is crucial for growth and development of specific cell 
types in multicellular organisms. One primary means of cell communication is through cell 
signaling pathways. Individual cells signal to surrounding cells, providing them with 
instructions for differentiation, growth and even apoptosis (Artavanis-Tsakonas et al., 1999).  
Notch signaling is one such communication pathway and is responsible for important 
developmental changes in organisms ranging from Drosophila melanogaster to Homo 
sapiens. When Notch signaling is disrupted, severe developmental defects can occur. Early 
studies in Drosophila showed that various Notch mutations caused hypertrophic growth of 
neural tissue, accompanied by significant hypotrophy of epidermal tissue (Jimenez and 
Campos-Ortega, 1982; Xu et al., 1990).  This results from the Notch pathway controlling the 
differentiation of cells by lateral inhibition. Neural cells normally develop in clusters: a 
central cell is determined to become a neuroblast, and signals to the surrounding cells to shut 
off their proneural genes, resulting in their adopting an epidermal fate (Technau et al., 1987). 
Without the Notch pathway to signal to the surrounding cells, none of the proneural genes are 
shut down, producing a phenotype with no epidermis and hypertrophic neural tissue (Heitzler 
and Simpson, 1991). Other studies in mammalian systems showed that Notch also controls 
cell differentiation in systems outside of neurogenesis, such as controlling cell fate in the 
endocrine and exocrine pancreas (Apelqvist et al., 1999). Furthermore, Notch can direct cell 
fate not only through promoting differentiation, but by inhibiting cell differentiation as well, 
a mechanism by which Notch controls muscle cell fate (Shawber et al., 1996).  
 Problems resulting from mutations arising in the Notch pathway have been implicated 
in a number of human diseases. Such mutations can affect the development of the liver, heart, 
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skeleton, and kidneys. One example is Alagille syndrome, which is caused by mutations in 
either the Jagged1 ligand or the Notch2 receptor (Oda et al., 1997). Another example is 
Hajdu-Cheney syndrome, which is linked to a mutation in the Notch2 receptor and is 
responsible for osteoporosis, renal cysts, and problems with craniofacial bone structure in the 
craniofacial region (Iwaya et al., 1979). Mutations in other Notch receptors have been 
implicated in cardiac disease, and cerebral autosomal dominant arteriopathy with subcortical 
infarcts and leukoencephalopathy (CADASIL; Penton et al., 2012).   
The Notch pathway is extremely conserved, and therefore research on Drosophila has 
clinical relevance for humans, despite minor differences between the mammalian and 
Drosophila Notch systems. These differences include the mammalian receptor undergoing 
additional processing prior to its presentation on the cell membrane (Kopan and Ilagan, 2009; 
Westhoff et al., 2009). Many features that control the Notch pathway remain unknown. 
While the receptor molecule must undergo a series of proteolytic processing steps that allows 
the signal to reach the nucleus, the ligands, which interact with and regulate the receptor, are 
also similarly processed for a currently unknown reason. Therefore, the purpose of my 
experiments in this work is to provide insight into what role ligand processing, specifically 
metalloprotease cleavage has on Notch activation. This is achieved by generating a novel 
form of the ligand Serrate.  
Structure of Notch Receptor 
Drosophila melanogaster has long been a favored research animal by geneticists for a 
variety of reasons. It has a relatively short life cycle and produces many offspring in a short 
period of time. Compared to many species, it also has relatively simple genetics with its 
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genome consisting of merely four pairs of chromosomes. The Notch pathway has been 
extensively studied in Drosophila, and it is the focus of this thesis. 
 The Notch gene product functions as a signal receptor and belongs to a group of 
single-pass transmembrane proteins (Wharton et al., 1985).  This receptor interacts with the 
Delta/Serrate/Lag-2 (DSL) family of ligands to constitute the major interacting elements of a 
cell-signaling pathway (Fehon et al., 1990).  Drosophila Notch is a single protein and was 
first characterized by analyzing the mRNA sequence obtained through the overlapping of 
cDNA clones (Wharton et al., 1985). After determining the DNA base pair sequence of 
Notch, the correct reading frame was determined and a predicted protein, of ~300 kDa in size, 
was isolated. The protein indicated the presence of an extracellular domain, a transmembrane 
domain and an intracellular domain. 
The Notch receptor’s extracellular domain (NECD) includes 36 epidermal growth 
factor (EGF)-like repeated sequences (ELRs), which play a key role in proper Notch 
signaling, as well as three lin12-Notch (LNR) repeats that are also cysteine-rich (Fig. 1). 
ELRs 11 and 12 play a key role in Notch’s ability to interact with both the Delta and Serrate 
ligands and are sufficient to induce cells expressing Notch or Delta to aggregate (Rebay et al., 
1991). This structure-function specificity appears highly conserved, as repeats 11 and 12 
serve the same role in the Xenopus Notch homolog. However, the remaining ELRs appear to 
have contrasting effects in Notch-Delta and Notch-Serrate interactions in Drosophila. 
Normally, the binding of the receptor and ligand surface proteins causes cells in culture to 
stick together in aggregations. Removal of extraneous ELRs causes an increase in 
aggregation of Notch-Delta cells, but it produces no such increase in the aggregation of 
Notch-Serrate cells (Rebay et al., 1991). 
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The ELRs play a key role in maintaining the structural integrity of the Notch 
molecule. Each ELR has six highly conserved cysteines that generate disulfide bonds and 
provide a highly consistent structure, even with some variation in the composition and 
number of other non-cysteine amino acids in the repeat (Fig. 2). ELRs 24 through 29 have 
been implicated in ligand interactions that inhibit  Notch signaling (Kelley et al., 1987). 
ELRs also bind calcium ions, which 
influence the receptor’s affinity for the 
ligand during activation and inhibition 
(Cordle et al. 2008).  
 
The Notch intracellular domain (NICD) contains several structural motifs, including  
a large segment of repeating glutamines, known as OPA, for which no purpose has been 
determined, 6 cdc10/ankyrin repeats (ANK), nuclear localization sequences (NLS) that 
ensure the NICD goes to the nucleus, a RBPjk association module (RAM), which has a high 
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Figure 2: Structure of an EGF-like repeat. It 
has 6 highly conserved cysteines (red) that 
maintain the structure with disulfide bonds 
(Yamamoto et al., 2012). 
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Figure 1: The Notch receptor protein structure. The 
extracellular domain consists of 36 ELRs and 3 LNR repeats. 
The intracellular domain consists of the RAM region, 7 
cdc10/ANK repeats, Nuclear localization sequences (NLS), a 
polyglutamine chain called the OPA, as well as a PEST 
region that controls degradation 
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affinity for binding to various transcription factors in the nucleus and finally a PEST domain 
that controls the degradation of the NICD (Struhl and Adachi, 1998; Deregowski et al., 2006, 
Kopan and Ilagan, 2009). In addition to the intracellular and extracellular domains, the Notch 
receptor has a transmembrane domain (TMD), which is responsible for bridging the cellular 
membrane and anchoring the protein in place. Once the receptor has bound to a ligand to 
activate the signaling pathway, it undergoes several cleavages that first remove the 
extracellular domain and then the intracellular domain from the molecule.  
Notch Ligands 
The receptor alone is not capable of activating the signaling pathway and is regulated 
through its interaction with the ligands, resulting in either activation or inhibition. Several 
ligands of Notch exist in mammals, Drosophila and C. elegans. The best studied ligands 
belong to the DSL (Delta/Serrate/LAG-2) family, (although other ligands may exist; Kopan 
and Ilagan, 2009). Each ligand in this family is identified by three structural motifs, a DSL 
region found at the N-terminal end of the extracellular domain, a DOS  domain (Delta and 
OSM-11-like proteins),  and a series of ELRs, similar those found in the Notch receptor itself 
(Fig. 3).   While the ligand Serrate and its mammalian homolog Jagged consist of 14  and 16 
ELRs respectively,  and have a cysteine-rich domain, the ligand Delta (in mammals) has only 
eight or nine ELRs and lacks the cysteine-rich domain (Kopan and Ilagan 2009). ELRs 4-6 of 
Serrate are known as the Notch-inhibitory region (NIR) and when any single repeat is 
removed the ligand loses all inhibitory function (Fig. 3A; Fleming et al., 2013). These 
ligands are also transmembrane proteins and therefore have a transmembrane domain and 
intracellular domain as well.  
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Mechanism of trans-activation/cis-inhibition 
The membrane bound Notch receptor interacts with its ligands in two specific ways, 
trans-activation and cis-inhibition. The first ligand-receptor interaction occurs when both 
proteins are present on the same cell membrane. In this case, the ligand interacts with the 
receptor in a currently unknown manner and prevents the receptors from undergoing trans-
activation with any adjacent cells (Fig. 4A). This process is known as cis-inhibition 
(Jacobsen et al., 1998). When the Notch receptor and a ligand are present on separate, but 
adjacent cells, the ligand binds to at least ELRs 11-12 in Notch. This creates a 
conformational change, revealing an extracellular metalloprotease cleavage site, and 
subsequently initiating the extracellular cleavage of the Notch protein called S2 (Fig. 4B; 
Mumm et al., 2000). 
B 
 
 
Intracellular 
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domain 
NIR 
 
A B 
Figure 3: A) Structure of the Serrate ligand, characterized by a DSL domain, 
14 ELRs and a cysteine-rich domain. B) The structure of the Delta ligand 
consisting of the 9 ELRs and lacking a cysteine-rich domain. 
  
8 
 
 
Proteolytic Cleavage of the Receptor Protein 
The kuzbanian (kuz) gene codes for an ADAM (a disintegrin and metalloprotease) 
protein that is responsible for the extracellular cleavage in Notch receptor processing prior to 
signal transduction. This protein has a conserved zinc-binding region as well as several 
cysteines that allow the binding of integrin receptors. The kuz protein shares a close 
homology with a mammalian homolog, BMP (bovine metalloprotease) and other ADAM 
proteins cause proteolytic cleavages to Notch as well, such as TACE (TNF-alpha converting 
enzyme), which uses a proteolytic cleavage to release TNF-α from its transmembrane domain 
(Brou et al., 2000).  In Notch, this cleavage allows for the shedding of the extracellular 
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 Intracellular 
Extracellular 
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Figure 4: Regulation of Notch pathway through ligand-receptor interactions. A) Cis-inhibition: The receptor and ligand are 
present on the same cell surface, so the receptor is prevented from interacting with the adjacent ligand. B) Trans-activation: 
The Notch receptor binds to the ligand, which triggers a conformational shift, allowing the receptor to be cleaved and 
activating the signal 
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domain, which subsequently leads to another cleavage of Notch by a γ-secretase (Mumm et 
al., 2000).  
After the extracellular cleavage of Notch by ADAM, the NECD is endocytosed by the 
ligand-expressing cell (Shimizu et al., 2002). This allows room for a presinilin/γ-secretase, 
which may normally be blocked by the presence of the extracellular domain, to interact with 
and cleave the intracellular domain of Notch at the S3 site (Fig. 4B). This initiates 
transcription regulation by releasing the intracellular domain into the cell. 
Following the intracellular S3 cleavage by γ-secretase, the Notch intracellular domain 
(NICD) moves to the nucleus and regulates transcription through a series of nuclear 
intermediates. One such nuclear factor is the Suppressor of Hairless (Su(H)), which requires 
the ankyrin (ANK) repeats of the NICD to be sequestered in the cytoplasm (Fortini and 
Artavanis, 1994). Once the Notch receptor is bound in trans to the ligand, Su(H) is 
translocated into the nucleus. The ANK repeats then interact with the Su(H) protein to recruit 
Mastermind, a coactivator necessary for recruiting a transcription activation complex (Kopan 
and Ilagan 2009).  
Ligand Processing 
 Protein cleavages are not only necessary for the receptor to function properly, but are 
crucial for the ligand as well. The ligands Serrate and Delta are cleaved extracellularly by 
metalloproteases produced by kuzbanian or TACE (Lavoe and Selkoe, 2003;Qi et al., 1999). 
However, when secreted forms of these ligands were expressed, that are comparable to forms 
that result from ADAM cleavages, they generated a phenotype similar to loss of function 
Notch mutation (Sun and Artavanis-Tsakonas, 1997). It is postulated that the ligands must 
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undergo a special endocytosis to activate Notch (Parks et al., 2000). After binding to the 
receptor protein, the ligand is then tagged with ubiquitin (Deblandre et al., 2001). This allows 
epsin to trigger the endocytosis of the ligand, which tugs on the NECD to reveal a 
metalloprotease cleavage site (Wang and Struhl, 2004). Given the Parks model of Notch 
activation (2000), cleaving the extracellular domain of the ligand might reduce its ability to 
cause a conformation change in the receptor, hence antagonizing Notch activation and 
emphasizes the sequence of events necessary for activation.  
Effect of Altering the Ligand Protein Structure 
Altering the structure of Serrate can have a significant impact on the ligand’s ability 
to activate Notch. The Serrate construct Minigene is a truncated form of the ligand that only 
contains the signal peptide, DSL domain, and the first six ELRs in the extracellular domain 
(Fig. 5B). This construct was unable to activate Notch when ectopically expressed (Fig. 6E; 
Fleming, personal communication). However, adding a 65 amino acid sequence to the 
extracellular domain of Serrate restored its trans-activation capabilities (Fig. 6K).  
 
 
Intracellular 
Extracellular 
 
 
 
DSL 
 
Cysteine-
rich 
domain 
NIR 
 
  
 
DDR
 
A B C D 
 
ELRs 
Figure 5: Variations of the Serrate molecule. A) Wild-type Serrate. B) Minigene Serrate construct with a truncated 
extracellular domain containing the first 6 ELRs, and a small amino acid chain directly adjacent to the 
transmembrane domain. C) DDR2 Serrate construct containing the minigene construct with a DDR2 
transmembrane domain substituted in. D) DDR265 Serrate construct containing the DDR2 construct with an 
additional 65 amino acids added immediately adjacent to the transmembrane domain. 
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Figure 6: Previous Serrate constructs and their ability to activate and inhibit Notch. A, D, G, and J) show ectopically 
expressed ptc-Serrate using GFP in several different constructs. B, E, H, and K) Cut expression of Notch activation 
in various Serrate constructs. C, F, I, L) merged images of the other images. B) Trans-activation and cis-inhibition of 
Notch in ectopically expressed wild-type Serrate. The white line indicates cut expression when no ectopic Serrate is 
present. E) Minigene construct, a truncated Serrate that only has the first 6 ELRs, only produces cis-inhibition, and 
no trans-activation of Notch. H) Ncleave7, a construct that changed one amino acid in the metalloprotease cleavage 
site, produces excess Notch activation. K) MG65, a construct that includes minigene and 65 additional amino acids, 
produces wild-type trans-activation and cis-inhibition.  
G H I Ncleave7 
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Figure 7: Western Blot showing the cleavage rate of minigene (MG) and MG65. The extracellular domain of the 
minigene is significantly more abundant than that of the MG65, indicating that MG is cleaved at a much higher rate 
than MG65 (Fleming, personal communication). The MG65m lane shows the cleavage rate of a mutated MG65 
construct.  
Furthermore, the minigene construct has also been shown to cleave at a significantly 
higher rate than MG65 (Fig. 7) which indicates that a correlation between the rate of 
cleavage and Notch activation capacity may exist. The first attempt to test this correlation 
resulted in the creation of the Ncleave7 construct, which substituted two amino acids in the 
metalloprotease cleavage site, in an effort to block the cleavage from occurring. While 
Ncleave7 did produce an over activation of Notch, (Fig. 6H) it was later determined that the 
cleavage was not completely prevented (Fleming, personal communication).  
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Goals of the project 
As stated previously, while the cleavages of the Notch receptor serve the clear 
purpose of facilitating the release of the NICD, the purpose of cleaving the ligands is still 
unknown. Based on the initial evidence provided by previous constructs (Fig. 6, 7), we 
theorized that the cleavage of the ligand Serrate functions as a down regulator of the Notch 
signal. To study this phenomenon, I sought to interrupt the metalloprotease cleavage of 
Serrate. Discoidin domain receptors (DDR) are a group of transmembrane tyrosine kinase 
proteins that control the interactions between cells and collagen. While DDR1 has been 
shown to be cleaved by metalloproteases such as membrane-type matrix metalloproteinase 
(MT-MMP) and release an extracellular domain in a manner similar to Serrate and Notch, 
the transmembrane domain of DDR2 undergoes no such cleavage by a metalloprotease (Fu et 
al., 2013). The cDNA encoding the transmembrane and juxtamembrane regions of the DDR2 
was used to replace the comparable region of Serrate to eliminate metalloproteinase cleavage. 
The first goal of this project was the generation of a Serrate minigene molecule, with the 
transmembrane domain substituted for the theoretically uncleavable DDR2 (discoidin 
domain receptor) transmembrane domain from humans. Theoretically, if the cleavage of the 
ligand is stopped, then the ligand will always trigger the conformational change, and Notch 
will activate at a much higher rate.  
In order to observe the effect of ectopically expressed DDR2 Serrate on Notch, and 
consequently its effect on wing development in D. melanogaster, the construct is linked to 
the patched (ptc) promoter and the Gal4/UAS expression system with green fluorescence 
protein (GFP) acting as the reporter gene (Brand and Perrimon 1993). This allows the 
expression of Serrate to occur ectopically in a known pattern and can be measured using the 
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GFP. The second goal was to create a construct similar to DDR2, but with the Serrate MG65 
molecule, rather than the minigene as the basis for the construct. If the new construct results 
in an overexpression of Notch, then it is very clear that some portion of the 65 additional 
amino acids interacts in a presently unknown manner with the Notch receptor, and would 
further the hypothesis that the cleavage acts to down regulate Notch.    
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Materials and Methods 
Creation of Serrate Construct DDR2 
 The initial DNA used was the full-length Serrate Bsp tom DNA in pUAST attB 
vector (Biscof, et al. 2007), and is called Xho+. Xho+ was initially cut with the restriction 
digest enzymes XhoI and XbaI (NEB) simultaneously. The DNA from pUAST attB Xho+ #4 
(Fleming, personal communication) was used as a control. For all digests, a lambda/Hind III 
ladder (NEB) was used for fragment size estimations. Inoculations were made of the DDR2 
construct, which was initially synthesized and cloned by InVitrogen. These inoculations were 
purified according to the same procedure mentioned previously. Each inoculation was 
analyzed using Nanodrop to determine the concentration of the DNA.  
Using gel electrophoresis, the Xho+ digest was separated out on using the Extraction 
Kit procedure (www.qiagen.com). A ligation of the two DNA fragments was performed 
using Thermo Quick Ligase according to the Rapid DNA Ligation Kit procedure (Thermo 
Scientific). The ligated DNA (XhoDDR2) was transformed into NEB 5-alpha competent E. 
coli (NEB) according to the manufacturer’s protocol and plated in varying quantities onto 
LB/AMP agar plates. PCR was used to determine if the insert was correct with the primer 
Xho3 end (5’GCGTCTGGCTTATCGCTCGAGTTCGGGAATGAACTTAAC3’) and primer 
5119-5080 (5’CACACTGTGTAGGATGTTCTTAGCGAAGAGAAGAGT3’), with Bsp tom used 
as a control. In order to test the orientation of the insert, both samples were digested 
sequentially with first XbaI and then EcoR1.  
Both XhoDDR2 and an additional sample of Xho+ #4 were digested sequentially with 
XbaI and EcoR1, and the lowest band from both digests were isolated and purified according 
to the QIAquick Gel Extraction Kit procedure (www.qiagen.com) over a single column. 
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These fragments were ligated with a pUAST attB vector that had been cut with EcoR1, using 
the ligation procedure (Thermo Scientific). NEB 5-alpha competent E. coli (NEB) was used 
for the transformation, and the cells were plated on LB/AMP agar plates in varying quantities.  
Each sample was prepped for sequencing first by increasing the concentration of each 
sample by using vacuum dehydration (Savant SpeedVac Plus SC110A). One microgram of 
DNA was resuspended, and the primer 4336 
(5’GCCGGTGGCCGCTCTTAGGAACTGGTGCTGCC3’) was added to the solution. These 
samples were sequenced by Genewiz through the University of Connecticut Molecular Core 
Facility. The final DNA construct was sent to Genetic Services, Inc. where it was injected 
into Drosophila embryos to generate transgenic lines.  
Drosophila crosses used for phenotypic observations 
To determine the phenotypic effects of the constructs, several crosses involving the 
injected flies were necessary. Virgin females were collected from the promoter constructs 
H2S2/H2S2 or ptc;Gal4 UAS GFP lines. These females were crossed separately with males of 
the DDR2/attp2 homozygous lines. The H2S2/H2S2 cross was placed in 25°C incubation, 
while the ptc;Gal4 UAS GFP cross was placed in 18°C to slow development to avoid 
embryonic lethality associated with high levels of expression.  After 3 days, the adults were 
moved to fresh tubes of food in to grow the fly lines. This process was repeated several times 
until sufficient animals were obtained.  
Wing Dissection 
As the adult Drosophila from the H2S2/H2S2 cross emerged from their pupal cases, the 
wings were removed from adult flies and stored in xylene. Approximately ten wings were 
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placed on a microscope slide, and excess xylene was removed. Permount (Fisher Scientific) 
was used to mount the wings, and a coverslip was placed on the slide. This was allowed to 
dry for several hours.  
Immunofluorescence Staining 
Larvae from the ptc;Gal4 UAS GFP cross were dissected in phosphate buffered saline 
(PBS), and the imaginal wing discs, while still attached to the larval heads, were placed in 
4% paraformaldehyde in PBS for approximately 20 minutes. The heads were washed with 
PBS four times. At this point, the PBS was replaced with blocking solution (1X PBS, 0.002% 
Saponin and 0.003% Normal Goat Serum), and the wing discs were kept at a cool 
temperature for 2 hours. The blocking solution was replaced, and 15µL of primary antibody 
mouse anti-cut 2B10 (Developmental Studies Hybridoma Bank) was added, and incubated 
overnight. The following day, primary antibody solution was removed and the wing discs 
were washed with 4 changes of PBS, and placed in fresh blocking solution. After several 
hours, the blocking solution was replaced with 1 µL of the secondary antibody Alexa Fluor 
546 goat anti-mouse IgG and allowed to incubate overnight. The following day, heads were 
again washed with PBS 4x, and placed in fresh blocking solution. The wing discs were 
mounted on microscope slides, and were isolated from the larval heads. Excess solution was 
removed, and the discs were covered in glycerol. The wing discs were coverslipped and 
observed using a Nikon E600 epi- fluorescent microscope and Spot Diagnostics Software. 
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Figure 8: A simplified diagram showing the restriction digests and ligations necessary to generate the 
SerDDR2 construct. A) Xho+ Bsp tom was digested with XbaI/XhoI and the smaller fragments were 
removed. B) DDR2 synthesized DNA digested with XbaI/XhoI and the smaller fragment was kept. C) The 
result of ligating A and B, this was digested with EcoR1/XbaI. D) Same DNA from A, digested with 
EcoR1/XbaI and the Xba fragment removed E) Bsp tom digested with EcoR1. F) The result of ligating C, 
D, and E together. 
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 Results 
Construction of SerDDR2 
The putatively uncleavable construct SerDDR2 was successfully created by replacing 
the transmembrane domain of the minigene Serrate with the transmembrane domain of the 
human DDR2 protein.  Figure 8 shows the fragments produced by the XhoI/XbaI digest of the 
DDR2 inserted piece and the Xho+ vector. The smaller of two fragments of DDR2 (Fig. 9, 
lane 1) was isolated from the gel and purified, as was the larger fragment from Bsp tom Xho+ 
(Fig. 9, lane 4). 
 
Figure 9: The gel electrophoresis of the XhoI/XbaI restriction digest. Lane 1. DDR2 cut with XhoI/XbaI. 
The lower band was extracted and purified for further use (circled). Lane 2. Uncut DDR2 used as a 
control. Lane 3. HindIII lambda ladder used for fragment size determination. Lane 4. Xho+ cut with 
XhoI/XbaI. The upper band was extracted and purified for further use (circled). Lane 5. Uncut Xho+ 
used as a control.  
 
3 1 2 4 5 
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Following the successful ligation of the two fragments from the XhoI/XbaI digest (Fig. 
8C), the XhoDDR2 construct was subsequently digested by EcoR1/XbaI, as was Bsp tom 
Xho+. Figure 10 shows the resulting fragments produced by the digest, excluding Xho+. The 
lower band (Fig. 10, Lane 1) was extracted and purified.  This fragment was then ligated with 
the fragment obtained from Xho+, as well as Bsp tom attB that had been digested with EcoR1 
alone (Fig 8C-F).  
           
Figure 10: An EcoR1/XbaI restriction digest used as a test for two different samples of XhoDDR2. Lane 1. 
The first sample of XhoDDR2 with the desired fragment present (circled). Lane 2. The second sample of 
XhoDDR2 lacking the desired fragment. Lane 3. MG65 DNA also digested with EcoR1/XbaI to serve as a 
control. Lane 4. HindIII lambda ladder for fragment size comparison. 
 
Several colonies resulted from the previously mentioned ligation, so a 50-colony PCR 
was performed (Figure 11).  Many samples showed the presence of the correct insertion band, 
 
4 3 2 1 
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and several were used for further testing (Lanes 1, 2, 3, 6, 9, 10, 14 and 15). Ultimately, 
samples from lanes 3 and 6 were sent for DNA sequencing and verification, and both 
appeared to have the correct sequence. 
 
 1    2   3    4    5   6    7                8   9   10 11  12 13 
  14 15  16 17  18 19  20 21  22              23 24  25 26  27 28 29  30  
Figure 11: 50-colony PCR of the SerDDR2 construct following the final ligation. HA3 
primer and 5119-5080 primer were used, and HAMG DNA was used as a control. Lanes 
with the desired band (such as the one circled) indicate the correct ligation. Each of these 
was later tested for the orientation of the insert. Lanes 3, 6, and 15 were tested and all had 
the insert in the correct orientation. The samples from lanes 3 and 6 were sent for 
sequencing.  
30 31 32  33 34  35 36  37 38 39  40       41  42 43 44  45 46 47  48  49 50 
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Figure 12: Imaginal wing discs of the H2S2/ H2S2 and ptc; Gal4 UAS GFP cross. Dorsal is up and posterior 
is to the right in each panel. A) A wild-type wing disc showing ectopic Serrate expression under the 
patched (ptc) promoter using green fluorescence protein (GFP) (Fleming, personal communication). B) 
CUT expression of Notch activation affected by ectopic Serrate in a wild-type disc. Cut is expressed 
adjacent to Serrate expression in ventral disc areas (red stripes). Notch is not activated where Serrate is 
expressed at high levels, as seen by the gap in CUT expression. C) Merged image of A and B. D) ptc-GFP 
expression of Serrate in the DDR2 construct. E) CUT expression of Notch activation in the DDR2 
construct. Gap in CUT expression across the margin is present. F) Merged image of D and E 
Upon completion of the SerDDR2 construct, genetic crosses were performed to 
express the transgene in a pattern driven by the promoter of the gene patched (ptc). The 
imaginal wing discs were collected. The wing discs taken from the H2S2/ H2S2 and ptc;Gal4 
DDR2 
Merge 
E F
 
D 
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UAS cross were processed for Cut expression as a marker for Notch activity and observed 
(Fig. 12). 
When DDR2attp2 is expressed via ptc, strong cis-inhibition is observed (Fig. 12E).  
Occasionally, a very small amount of activation of Notch occurs on the posterior side of the 
patched Serrate expression pattern, in some discs (Fig. 12E,F). However, this activation is 
extremely limited compared to wild-type activation of Notch (Fig. 12B, C), and many discs 
showed no activation at all.  
The H2S2/ H2S2 and DDR/2attp2; A5/TM6 B cross produced several different 
phenotypes (Fig. 13). All flies developed wings, but the vast majority of flies produced 
dominant-negative wings, a scenario in which the altered copy of Serrate inhibits the wild-
type copy. These wings display severely stunted growth and heavy wing veination (Fig. 13G, 
H). A smaller percentage of animals showed wings with severely nicked edges, similar to the 
phenotype produced by Serrate mutants (Fig. 12E and F).  
Construction of SerDDR265 is currently in progress, following the same procedures 
used for the construction of SerDDR2. However, this construct uses MG65 as its framework 
rather than the minigene, and therefore contains the additional 65 amino acids that were 
shown to restore Notch activation (Fig. 6K). This should allow us to determine if the 
cleavage of Serrate has an effect on Notch activation independent of the effect of the 
additional amino acids.  
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Figure 13: Wings collected from the H2S2/ H2S2; DDR/2attp2 cross with ptc expressed Serrate. A) Wild-
type adult wing that is phenotypically normal. B) Wild-type wing with a wild type Serrate construct 
expressed by H2S2. C) Wing expressing activated Serrate construct via H2S2. D) Wing expressing a 
dominant-negative Serrate construct via H2S2 E), F) Adult wings expressing DDR2/attp2 via H2S2 
displaying severe wing nicking, but still somewhat developed. G), H) Adult wings expressing DDR2/attp2 
via H2S2 displaying the dominant-negative phenotype with severely reduced wing size and inhibited 
development. All images are at same magnification.  
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Discussion 
The results produced by the SerDDR2 construct, as shown in the adult wings and 
imaginal wing discs (Fig. 11,12), do not support the hypothesis that the cleavage of Serrate 
functions as a down regulator of Notch activation.  Previous studies have shown that forms of 
Serrate such as the minigene construct, which are cleaved at a significantly higher rate than 
wild-type Serrate, also lack activation capacity. However, Serrate constructs such as MG65, 
which are cleaved  at levels significantly lower than the minigene (Fig. 7), are capable of 
activating Notch at levels equivalent to wild-type as well (Fleming, personal communication).  
Therefore, it appears that the cleavage rate of Serrate may be inversely correlated to the rate 
of Notch activation.                    
I predicted that preventing the cleavage of Serrate would increase activation of Notch  
drastically.  Hence a phenotype in wing discs comparable to that seen in Figure 6H was 
expected of the SerDDR2 construct. On the contrary, the SerDDR2 construct resulted in 
primarily Notch inhibition with perhaps an extremely small amount of Notch activation in 
some discs. This could be explained by several different possibilities as outlined below.  
The MG65 Serrate construct differs from the minigene construct by the presence of 
an additional endogenous 65 amino acids chain located adjacent to the transmembrane 
domain. This additional chain of amino acids has very little homology with the same region 
in the mammalian homologous ligand Jagged (Lindsell et al., 1995), and no additional 
functions have been attributed to this region so far (Fleming, personal communication). 
However, the additional 65 amino acids allow MG65 to activate Notch at a significantly 
higher rate than the minigene construct. This suggests that a previously undescribed 
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component in these 65 amino acids contributes to proper activation of Notch.  Part of the 
reason for constructing DDR265 is to further examine whether that additional chain can 
permit Notch activation, in the absence of a metalloprotease cleavage in the DDR2 construct.  
It is possible that the cleavage does, in fact, down regulate Notch activation, but that 
activation itself requires an additional component not present in DDR2. Without this 
unknown component, Notch may not activate at significant levels regardless of  ligand 
cleavage. This could explain the largely dominant-negative effects observed in the adult 
wings (Fig. 13G, H) when DDR2attP2 is expressed with an occasional hint of activity in 
some wings (Fig. 13E, F).  
Most adult wings observed from the SerDDR2 construct produced the dominant-
negative phenotype (Fig. 12G, H). This is consistent with adult wing phenotype observed 
previously in the minigene construct (Fleming, personal communication), indicating that 
Notch activation does not occur, or occurs in very small amounts. However, several 
individual flies produced wings that were much more developed, and thus do not display as 
strong of a dominant-negative phenotype, though these flies were not nearly as abundant as 
the other phenotype.  Wings that were not dominant-negative were characterized by severe 
wing nicking, a trait often present in flies with reduced Notch activation (Fleming, personal 
communication; Thomas et al., 1991).  This suggests that in some SerDDR2 flies, Notch 
activation was partially restored. Unfortunately, because this phenotype is not present in all 
offspring, it seems unlikely that it is solely the result of the SerDDR2 construct. Ultimately, 
the cause of the unexpected phenotype is still unknown.  
Another factor that could be influencing the results is the substituted SerDDR2 
transmembrane domain itself.  While it has been shown to not be cleaved in humans, its 
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cleavage or non-cleavage has not yet been verified in Drosophila (Fu et al., 2013). Many 
components that control metalloprotease cleavage have not yet been fully described, and it is 
possible that some of these could initiate a cleavage of the DDR2 transmembrane domain in 
flies in a manner that has not been observed in humans. If so, the SerDDR2 construct could 
still be getting cleaved, which would then down regulate Notch. It will be necessary to 
measure the abundance of cleaved material using a western blot to rule out this scenario as an 
explanation. Consistent with this explanation are the properties of metalloproteases 
themselves. 
 Metalloprotease cleavage sites are shown to be more “fluid” than many types of 
proteases because they are less sequence specific (Fu et al., 2013). Despite altering an amino 
acid within the cleavage site of the Serrate construct Ncleave7 and having this result in 
excessive Notch activation when expressed, the protein was still capable of being cleaved 
(Fig. 7; Fleming, personal communication). Therefore, it is possible that the SerDDR2 
construct is still cleaved, despite the complete absence of the metalloprotease cleavage site 
used in humans.  
Construction of SerDDR265 is still in progress due to a number of technical problems, 
specifically issues relating to ligations. Once it is completed, the results should provide 
insight into the role of ligand cleavage on Notch activation. If the additional 65 amino acids 
present in the MG65 construct that restore its ability to activate Notch similar to wild type 
Serrate are important for its activity, then I predict that the SerDDR265 construct will over-
activate Notch (Fig. 14). This is based on the idea that the cleavage functions as a down 
regulator, because SerDDR265 would essentially be an uncleavable form of MG65. However, 
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if SerDDR265 does not over activate Notch, then it is possible that the cleavage itself might 
be required for Notch activation, rather than serving as a down regulator.  
For further study, a control construct that contains an additional 65 amino acids that 
are not native to Serrate would help confirm if some factor in that region plays a key role in 
Notch activation. Otherwise, the ligand may rely on a spacing mechanism to activate the 
receptor. If an unknown factor does exist, then it could revolutionize the current 
understanding of the ligand’s role in Notch.  
 
 
 
 
 
DDR
 
B 
C 
Figure 14: Variations of the Serrate molecule, cleavage rate and their effect on Notch. A) Ser minigene, a 
truncated form that displayed an increased cleavage rate and no Notch activation. B) DDR2 Serrate 
construct containing the minigene construct with a DDR2 transmembrane domain substituted in. It was not 
cleaved and produced no Notch activation C) DDR265 Serrate construct containing the DDR2 construct with 
an additional 65 amino acids added immediately adjacent to the transmembrane domain. This construct is 
not cleaved and should display increased Notch activation. D) Ser MG65, the minigene construct with an 
additional 65 amino acids attached. Displayed cleavage rates and Notch activation. 
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Cleavage: None 
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